These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11576827)

  • 1. Synthesis, hydrolysis kinetics and anti-platelet effects of isosorbide mononitrate derivatives of aspirin.
    Gilmer JF; Moriarty LM; McCafferty DF; Clancy JM
    Eur J Pharm Sci; 2001 Oct; 14(3):221-7. PubMed ID: 11576827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.
    Gilmer JF; Murphy MA; Shannon JA; Breen CG; Ryder SA; Clancy JM
    J Pharm Pharmacol; 2003 Oct; 55(10):1351-7. PubMed ID: 14607016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
    Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
    J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.
    Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Morelli A; del Soldato P; Minuz P
    Circulation; 2002 Dec; 106(24):3120-5. PubMed ID: 12473561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anti-platelet properties of molsidomine, isosorbide-5-mononitrate and placebo in healthy volunteers.
    Drummer C; Valta-Seufzer U; Karrenbrock B; Heim JM; Gerzer R
    Eur Heart J; 1991 Apr; 12(4):541-9. PubMed ID: 1648488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate.
    Gilmer JF; Moriarty LM; Lally MN; Clancy JM
    Eur J Pharm Sci; 2002 Sep; 16(4-5):297-304. PubMed ID: 12208460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate.
    Müller S; König I; Meyer W; Kojda G
    J Am Coll Cardiol; 2004 Aug; 44(3):624-31. PubMed ID: 15358031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
    Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
    Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evidence of an endothelial cell-dependent antiplatelet activity for isosorbide dinitrate, but not for its 2- and 5-mononitrate metabolites.
    Rolland PH; Berenger FP; Cano JP
    J Pharmacol Exp Ther; 1987 Jan; 240(1):234-40. PubMed ID: 3100769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New isosorbide 5-mononitrate derivative with hypotensive activity.
    Coppi G; Borella F; Gatti MT; Comini A; Dall' Asta L
    Boll Chim Farm; 1989 Feb; 128(2):74-6. PubMed ID: 2775521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
    Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
    Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte aggregation and fibrinolysis in healthy probands treated with molsidomine, isosorbide-5-mononitrate and placebo].
    Drummer C; Valta-Seufzer U; Spannagl M; Frey A; Lüdke S; Schramm W; Gerzer R
    Z Kardiol; 1991; 80 Suppl 5():43-6. PubMed ID: 1776334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
    Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
    Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
    J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic apoptosis-inducing effect of aspirin and isosorbide mononitrate on human colon cancer cells.
    Wang X; Diao Y; Liu Y; Gao N; Gao D; Wan Y; Zhong J; Jin G
    Mol Med Rep; 2015 Sep; 12(3):4750-4758. PubMed ID: 26094902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
    Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL
    Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-isosorbide mononitrate on isosorbide dinitrate-induced relaxation of rabbit aortic rings.
    Bennett BM; Tam GS; Van Alstyne K; Brien JF; Nakatsu K; Marks GS
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1194-7. PubMed ID: 6498631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibitory effects of isosorbide dinitrate and its mononitrate metabolites on platelet aggregation and thromboxane formation.
    Rolland PH; Sampol J; Lacarelle B; Arnoux D; Leca F; Gueydon E; Cano JP
    Pharm Res; 1985 Mar; 2(2):87-90. PubMed ID: 24272617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate.
    Pipili-Synetos E; Papageorgiou A; Sakkoula E; Sotiropoulou G; Fotsis T; Karakiulakis G; Maragoudakis ME
    Br J Pharmacol; 1995 Sep; 116(2):1829-34. PubMed ID: 8528567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.